MEDIFAST Historical Financial Ratios

MED Stock

USD 14.15 0.19 1.32%

MEDIFAST INC is lately reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.25 will help investors to properly organize and evaluate MEDIFAST INC financial condition quickly.

Quick Ratio Current Ratio

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

About MEDIFAST Financial Ratios Analysis

MEDIFAST INCFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate MEDIFAST INC investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on MEDIFAST financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across MEDIFAST INC history.

MEDIFAST INC Financial Ratios Chart

At present, MEDIFAST INC's Free Cash Flow Yield is projected to increase slightly based on the last few years of reporting. The current year's Operating Cash Flow Per Share is expected to grow to 2.48, whereas Dividend Yield is forecasted to decline to 0.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing MEDIFAST INC stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on MEDIFAST INC sales, a figure that is much harder to manipulate than other MEDIFAST INC multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is MEDIFAST INC dividend as a percentage of MEDIFAST INC stock price. MEDIFAST INC dividend yield is a measure of MEDIFAST INC stock productivity, which can be interpreted as interest rate earned on an MEDIFAST INC investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from MEDIFAST INC's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Free Cash Flow Yield is projected to increase slightly based on the last few years of reporting. The current year's Operating Cash Flow Per Share is expected to grow to 2.48, whereas Dividend Yield is forecasted to decline to 0.

	2022	2023	2024	2025 (projected)
Dividend Yield	0.0555	0.0998	0.003713	0.003527
Price To Sales Ratio	0.81	0.68	0.32	0.3

Dividend Yield Price To Sales Ratio

MEDIFAST INC fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		-0.13	0.8	-0.21	-0.22	-0.38	0.1	0.12	0.8	1.0	0.12	0.43	-0.01	0.21	0.08	0.08	-0.31	0.01	0.5	0.2	0.17	0.03	0.54	-0.17	-0.48	0.36
Dividend Yield	-0.13		0.06	-0.2	0.24	0.7	0.71	0.01	0.06	-0.13	0.72	0.45	0.5	0.57	-0.33	0.51	-0.18	0.14	0.05	0.08	0.48	0.04	-0.09	-0.36	-0.36	0.47
Ptb Ratio	0.8	0.06		-0.28	0.05	-0.21	0.51	0.48	1.0	0.81	0.49	0.84	-0.14	0.66	0.24	0.29	-0.3	0.17	0.48	0.64	0.04	0.09	0.55	-0.29	-0.47	0.79
Days Sales Outstanding	-0.21	-0.2	-0.28		-0.51	-0.6	-0.35	-0.2	-0.28	-0.14	-0.32	-0.31	-0.38	-0.29	0.52	-0.71	0.03	-0.52	-0.92	-0.27	-0.64	-0.93	-0.75	0.93	-0.26	-0.31
Book Value Per Share	-0.22	0.24	0.05	-0.51		0.52	0.48	0.2	0.05	-0.26	0.45	0.2	-0.09	0.44	-0.05	0.32	-0.44	0.91	0.37	0.4	-0.11	0.43	0.31	-0.42	0.63	0.24
Free Cash Flow Yield	-0.38	0.7	-0.21	-0.6	0.52		0.56	-0.15	-0.21	-0.43	0.57	0.15	0.56	0.27	-0.65	0.65	-0.02	0.44	0.29	0.0	0.55	0.52	0.01	-0.66	0.26	0.2
Operating Cash Flow Per Share	0.1	0.71	0.51	-0.35	0.48	0.56		0.25	0.51	0.1	0.99	0.82	0.19	0.88	-0.13	0.6	-0.38	0.44	0.23	0.5	0.19	0.12	0.11	-0.46	-0.22	0.84
Capex To Depreciation	0.12	0.01	0.48	-0.2	0.2	-0.15	0.25		0.48	0.15	0.12	0.59	-0.46	0.64	0.6	0.06	0.28	-0.02	0.33	0.65	-0.07	0.3	0.56	-0.12	-0.23	0.61
Pb Ratio	0.8	0.06	1.0	-0.28	0.05	-0.21	0.51	0.48		0.81	0.49	0.84	-0.14	0.66	0.24	0.29	-0.3	0.17	0.48	0.64	0.04	0.09	0.55	-0.29	-0.47	0.79
Ev To Sales	1.0	-0.13	0.81	-0.14	-0.26	-0.43	0.1	0.15	0.81		0.12	0.46	-0.05	0.23	0.14	0.04	-0.29	-0.04	0.43	0.21	0.12	-0.04	0.5	-0.11	-0.53	0.38
Free Cash Flow Per Share	0.12	0.72	0.49	-0.32	0.45	0.57	0.99	0.12	0.49	0.12		0.78	0.25	0.82	-0.2	0.6	-0.45	0.45	0.19	0.44	0.19	0.07	0.05	-0.45	-0.22	0.79
Roic	0.43	0.45	0.84	-0.31	0.2	0.15	0.82	0.59	0.84	0.46	0.78		-0.03	0.92	0.18	0.52	-0.23	0.16	0.38	0.66	0.13	0.13	0.4	-0.41	-0.5	0.99
Inventory Turnover	-0.01	0.5	-0.14	-0.38	-0.09	0.56	0.19	-0.46	-0.14	-0.05	0.25	-0.03		-0.08	-0.89	0.52	-0.02	0.02	0.23	-0.23	0.8	0.28	-0.02	-0.52	-0.17	-0.05
Net Income Per Share	0.21	0.57	0.66	-0.29	0.44	0.27	0.88	0.64	0.66	0.23	0.82	0.92	-0.08		0.24	0.45	-0.28	0.32	0.3	0.66	0.07	0.13	0.35	-0.35	-0.35	0.94
Days Of Inventory On Hand	0.08	-0.33	0.24	0.52	-0.05	-0.65	-0.13	0.6	0.24	0.14	-0.2	0.18	-0.89	0.24		-0.53	0.06	-0.21	-0.31	0.26	-0.7	-0.42	0.01	0.59	-0.17	0.18
Payables Turnover	0.08	0.51	0.29	-0.71	0.32	0.65	0.6	0.06	0.29	0.04	0.6	0.52	0.52	0.45	-0.53		-0.19	0.32	0.58	0.24	0.6	0.55	0.36	-0.91	-0.03	0.53
Capex To Revenue	-0.31	-0.18	-0.3	0.03	-0.44	-0.02	-0.38	0.28	-0.3	-0.29	-0.45	-0.23	-0.02	-0.28	0.06	-0.19		-0.59	-0.08	-0.12	0.25	0.27	-0.01	0.09	-0.12	-0.22
Cash Per Share	0.01	0.14	0.17	-0.52	0.91	0.44	0.44	-0.02	0.17	-0.04	0.45	0.16	0.02	0.32	-0.21	0.32	-0.59		0.4	0.42	-0.08	0.36	0.28	-0.43	0.62	0.18
Pocfratio	0.5	0.05	0.48	-0.92	0.37	0.29	0.23	0.33	0.48	0.43	0.19	0.38	0.23	0.3	-0.31	0.58	-0.08	0.4		0.3	0.58	0.85	0.93	-0.83	0.08	0.35
Interest Coverage	0.2	0.08	0.64	-0.27	0.4	0.0	0.5	0.65	0.64	0.21	0.44	0.66	-0.23	0.66	0.26	0.24	-0.12	0.42	0.3		-0.11	0.21	0.38	-0.25	-0.07	0.68
Payout Ratio	0.17	0.48	0.04	-0.64	-0.11	0.55	0.19	-0.07	0.04	0.12	0.19	0.13	0.8	0.07	-0.7	0.6	0.25	-0.08	0.58	-0.11		0.6	0.39	-0.7	-0.29	0.12
Capex To Operating Cash Flow	0.03	0.04	0.09	-0.93	0.43	0.52	0.12	0.3	0.09	-0.04	0.07	0.13	0.28	0.13	-0.42	0.55	0.27	0.36	0.85	0.21	0.6		0.73	-0.82	0.35	0.13
Pfcf Ratio	0.54	-0.09	0.55	-0.75	0.31	0.01	0.11	0.56	0.55	0.5	0.05	0.4	-0.02	0.35	0.01	0.36	-0.01	0.28	0.93	0.38	0.39	0.73		-0.62	-0.01	0.36
Days Payables Outstanding	-0.17	-0.36	-0.29	0.93	-0.42	-0.66	-0.46	-0.12	-0.29	-0.11	-0.45	-0.41	-0.52	-0.35	0.59	-0.91	0.09	-0.43	-0.83	-0.25	-0.7	-0.82	-0.62		-0.12	-0.41
Income Quality	-0.48	-0.36	-0.47	-0.26	0.63	0.26	-0.22	-0.23	-0.47	-0.53	-0.22	-0.5	-0.17	-0.35	-0.17	-0.03	-0.12	0.62	0.08	-0.07	-0.29	0.35	-0.01	-0.12		-0.46
Roe	0.36	0.47	0.79	-0.31	0.24	0.2	0.84	0.61	0.79	0.38	0.79	0.99	-0.05	0.94	0.18	0.53	-0.22	0.18	0.35	0.68	0.12	0.13	0.36	-0.41	-0.46

Click cells to compare fundamentals

MEDIFAST INC Account Relationship Matchups

MEDIFAST INC fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	2.47	1.61	0.81	0.68	0.32	0.3
Dividend Yield	0.023	0.026	0.0555	0.0998	0.003713	0.003527
Ptb Ratio	14.7	12.11	8.33	3.63	0.92	0.87
Book Value Per Share	13.36	17.3	13.85	18.51	19.22	20.18
Free Cash Flow Yield	0.0603	0.0246	0.14	0.19	0.0884	0.0928
Operating Cash Flow Per Share	12.34	8.08	17.38	13.57	2.24	2.48
Stock Based Compensation To Revenue	0.00727	0.006489	0.006914	0.007638	0.0122	0.0116
Capex To Depreciation	0.81	5.02	1.52	0.49	0.63	0.59
Pb Ratio	14.7	12.11	8.33	3.63	0.92	0.87
Ev To Sales	1.72	2.31	1.56	0.77	0.2	0.19
Free Cash Flow Per Share	11.83	5.15	15.89	12.97	1.56	2.04
Roic	0.6	0.7	0.77	0.43	0.007024	0.006673
Inventory Turnover	4.44	2.21	3.85	5.43	3.72	2.66
Net Income Per Share	8.74	14.01	12.82	9.13	0.19	0.18
Days Of Inventory On Hand	82.22	164.91	94.69	67.27	98.1	93.19
Payables Turnover	6.57	5.62	8.63	7.56	6.85	4.94
Research And Ddevelopement To Revenue	0.002995	0.002883	0.002815	0.004291	0.004934	0.004903
Capex To Revenue	0.006297	0.0224	0.0104	0.006047	0.0124	0.0118
Cash Per Share	14.82	9.36	7.83	13.79	14.85	15.6
Pocfratio	15.92	25.93	6.64	4.95	7.87	8.29
Payout Ratio	0.52	0.39	0.5	0.73	0.34	0.21
Capex To Operating Cash Flow	0.0405	0.36	0.0857	0.0439	0.3	0.32
Pfcf Ratio	16.59	40.63	7.26	5.18	11.31	11.88
Days Payables Outstanding	55.58	64.94	42.32	48.3	53.3	70.82
Income Quality	1.41	0.58	1.36	1.49	11.71	12.29
Roe	0.65	0.81	0.93	0.49	0.009952	0.009454
Ev To Operating Cash Flow	14.87	25.17	6.32	4.46	4.81	6.34
Pe Ratio	22.47	14.94	8.99	7.36	92.1	87.5
Return On Tangible Assets	0.37	0.41	0.45	0.32	0.007357	0.006989
Ev To Free Cash Flow	15.49	39.44	6.91	4.67	6.92	7.27
Earnings Yield	0.0445	0.0669	0.11	0.14	0.0109	0.0114
Net Debt To E B I T D A	(1.14)	(0.32)	(0.31)	(0.52)	(25.99)	(24.69)
Current Ratio	2.1	1.81	1.58	2.43	3.34	2.33
Tangible Book Value Per Share	13.36	17.3	13.85	18.51	19.22	20.18
Graham Number	51.25	73.85	63.22	61.68	9.1	14.58

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:

How To Invest In MEDIFAST

Details

Is MEDIFAST Stock a good investment?

Details

What is MEDIFAST INC's Net Worth?

Details

Largest Personal Care Products Companies

View

Largest Household & Personal Products Companies

View

For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.87)

Earnings Share

0.19

Revenue Per Share

55.12

Quarterly Revenue Growth

(0.38)

Return On Assets

0.0324

The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

MEDIFAST Historical Financial Ratios

About MEDIFAST Financial Ratios Analysis

MEDIFAST INC Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

MEDIFAST INC fundamentals Correlations

MEDIFAST INC Account Relationship Matchups

High Positive Relationship

High Negative Relationship

MEDIFAST INC fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 0.99	Operating Cash Flow Per Share
Roe	+ 0.99	Roic
Roe	+ 0.94	Net Income Per Share
Days Payables Outstanding	+ 0.93	Days Sales Outstanding

Capex To Operating Cash Flow	- 0.93	Days Sales Outstanding
Pocfratio	- 0.92	Days Sales Outstanding
Days Payables Outstanding	- 0.91	Payables Turnover
Days Of Inventory On Hand	- 0.89	Inventory Turnover
Days Payables Outstanding	- 0.83	Pocfratio
Days Payables Outstanding	- 0.82	Capex To Operating Cash Flow